In vitro and In vivo characterization of NOSO-502, a novel inhibitor of bacterial translation
E. Racine, P. Nordmann, L. Pantel, M. Sarciaux, M. Serri, J. Houard, P. Villain-Guillot, A. Demord, C. Vingsbo Lundberg, M. Gualtieri
This paper characterizes NOSO-502, a novel antibiotic that inhibits bacterial translation and shows efficacy against CRE and other pathogens in vitro and in vivo.
bioRxiv · May 24, 2018Microbiology